Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

within
I am searching for a
Reset Form
Lainie P. Martin, MD

Lainie P. Martin, MD Physician

Leader, Gynecology/Oncology Program Associate Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Martin is employed by Penn Medicine.

Request a Callback
No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients in a medical practice setting.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.
X

About Dr. Lainie P. Martin

Recognized in Philadelphia magazine's May 2018 Top Docs issue

Clinical Specialties

Specialty:

  • Gynecologic Oncology

Programs & Centers:

Board Certification:

  • Medical Oncology, 2006

Clinical Expertise:

  • Abdominal Chemotherapy
  • Abdominal Dermoid Cyst
  • Adenocarcinoma In Situ of the Cervix
  • Adenocarcinoma of Cervix
  • Adnexal Mass
  • Bartholin's Gland Carcinoma
  • CA 125 Elevation
  • Cancer During Pregnancy
  • Cancer of the Myometrium
  • Cancer of the Oviduct
  • Cervical Conization
  • Cervical Dysplasia
  • Cervical Intraepithelial Neoplasia
  • Choriocarcinoma
  • Cold Knife Cone Biopsy of the Cervix
  • Complex Pelvic Surgery
  • Dysgerminoma of Ovary
  • Endometrial Hyperplasia
  • Familial Ovarian Cancer
  • Glossectomy
  • Gynecologic Surgery
  • Hereditary Breast and Ovarian Cancer
  • HGSIL Pap Smear
  • Hydatiform Mole
  • Labial Cancer
  • Laparoscopic Oophorectomy
  • Laparoscopic Pelvic Lymphadenectomy
  • Leiomyoma
  • Leiomyosarcoma
  • Leiomyosarcoma of the Uterus
  • LGSIL Pap Smear
  • Malignant Neoplasm of Mesovarium
  • Ovarian Debulking Surgery
  • Ovarian Tumors
  • Paget's Disease of the Vulva
  • Partial Vulvectomy
  • Pelvic Lymphadenectomy
  • Pelvic Malignancy During Pregnancy
  • Pelvic Mass
  • Postmenopausal Adnexal Mass
  • Primary Peritoneal Cancer
  • Prophylactic Oophorectomy
  • Pseudomyxoma Peritonei
  • Radical Hysterectomy
  • Radical Trachelectomy
  • Radical Vulvectomy
  • Recurrent Cervical Cancer
  • Sentinel Lymph Node Biopsy
  • Squamous Cell Carcinoma of the Cervix
  • Squamous Intraepithelial Neoplasia
  • Surgical Staging
  • Teratoma
  • Teratoma of Ovary
  • Urethral Cancer
  • Uterine Mass
  • Vaginal Intraepithelial Neoplasia
  • Vulvectomy
Show All Expertise

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Temple University School of Medicine
Residency: Boston Medical Center (Formerly Boston City Hospital)
Residency: Fox Chase Cancer Center

Memberships

American Society of Clinical Oncology, National Cancer Genome Institute (CGI), National Gynecologic Oncology Group (GOG), National Minnesota Ovarian Cancer Alliance, National National Comprehensive Cancer Network (NCCN), National Uterine Task Force Gynecologic Cancer Steering Committee, National

Hospital Affiliation

Dr. Martin is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Westin SN, Sill MW, Coleman RL, Waggoner S, Moore KN, Mathews CA, Martin LP, Modesitt SC, Lee S, Ju Z, Mills GB, Schilder RJ, Fracasso PM, Birrer MJ, Aghajanian C.: Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study. Gynecol Oncol. 2019 Oct 15. pii: S0090-8258(19). doi: 10.1016/j.ygyno.2019.09.024. [Epub ahead of print] epub ahead of print (19): 31548-3,2019.

Birrer MJ, Betella I, Martin LP, Moore KN: Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age? Oncologist 24 (4): 425-29,2019.

Matulonis UA, Birrer MJ, O'Malley DM, Moore KN, Konner J, Gilbert L, Martin LP, Bauer TM, Oza AM, Malek K, Pinkas J, Kim SK: Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine. Clin Cancer Res 25 (6): 1727-36,2019.

Patel D, Handorf E, von Mehren M, Martin L, Movva S.: Adjuvant Chemotherapy in Uterine Leiomyosarcoma: Trends and Factors Impacting Usage. Sarcoma 2019 : 3561501,2019.

Falchook G, Coleman RL, Roszak A, Behbakht K, Matulonis U, Ray-Coquard I, Sawrycki P, Duska LR, Tew W, Ghamande S, Lesoin A, Schwartz PE, Buscema J, Fabbro M, Lortholary A, Goff B, Kurzrock R, Martin LP, Gray HJ, Fu S, Sheldon-Waniga E, Lin HM, Venkatakrishnan K, Zhou X, Leonard EJ, Schilder RJ: Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial. JAMA Oncol 5 (1): e183773,2019.

Moore KN, O'Malley DM, Vergote I, Martin LP, Gonzalez-Martin A, Malek K, Birrer MJ.: Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer. Gynecol Oncol 151 (1): 46-52,2018.

Burger RA, Deng W, Makker V, Collins Y, Gray H, Debernardo R, Martin LP, Aghajanian C.: Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol 150 (3): 466-70,2018.

Lheureux S, Butler MO, Clarke B, Cristea MC, Martin LP, Tonkin K, Fleming GF, Tinker AV, Hirte HW, Tsoref D, Mackay H, Dhani NC, Ghatage P, Weberpals J, Welch S, Pham NA, Motta V, Sotov V, Wang L, Karakasis K, Udagani S, Kamel-Reid S, Streicher HZ, Shaw P, Oza AM.: Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma. JAMA Oncol 4 (7): e173776,2018.

O'Malley DM, Martin LP, Gilbert L, Vergote I, Matulonis UA, Birrer MJ, Castro CM, Malek KS, González-Martín A, Moore KN.: Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-resistant ovarian cancer: Maturing safety and activity profile from the FORWARD II phase 1b study. The American Society of Clinical Oncology 2018 Meeting, Chicago, IL : 2018.

Martin LP, Jain A, Chu CS, Mantia-Smaldone G, Rubin SC, Ross E, Schilder RJ.: Phase I Study of Carboplatin (C), Pegylated Liposomal Doxorubicin (PLD) and Everolimus (E) in Platinum-Sensitive Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer In First Relapse (NCT01281514). American Society of Clinical Oncology 2018 Meeting, Chicago, IL : 2018.

Academic Contact Info

Perelman Center for Advanced Medicine
10th Floor, South Pavilion

Philadelphia, PA 19104
Patient appointments: 800-789-7366 (PENN)